Navigation Links
Nurse-Attorney/Former Bristol-Myers Squibb Executive Selected To Lead New Jersey State Nurses Association
Date:2/10/2010

TRENTON, N.J., Feb. 10 /PRNewswire/ -- The New Jersey State Nurses Association (NJSNA) today announced that Patricia A. Barnett, a nurse and attorney with three decades of public policy experience, has been selected as the new Chief Executive Officer of the Association by the Board of Directors. Barnett will begin her work at NJSNA on March 1st.  She replaces Dr. Barbara Wright, who has been serving as interim CEO following the retirement of longtime NJSNA CEO Andrea Aughenbaugh.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100210/PH52888 )

"We could not be more excited about the selection of Patricia to head our association," said Barbara Chamberlain, President of NJSNA. "Her skill-set and experience make her uniquely suited to lead NJSNA through what we are sure will be challenging times ahead in the rapidly changing world of health care."

Barnett served as Director and Government Affairs Manager for Bristol-Myers Squibb in Princeton from 1987 to 1993 and again in 1997 and 1998. She was Director of Economic and General Welfare for the Illinois Nurses Association in Chicago from 1979 until 1987. More recently, Barnett has served as Executive Director of Public Policy and Government Affairs for Forest Laboratories, Inc.

"I am thrilled to be given the opportunity to return to my roots and work exclusively on nursing issues," said Barnett. "I have 30 years experience impacting health policy and access to care at the city, state and federal level and I am eager to bring that experience to bear on behalf of New Jersey's 110,000 registered professional nurses."

A graduate of the Michael Reese Hospital School of Nursing, Roosevelt University and Loyola University School of Law, Barnett has served in both supervisory and line nursing capacities. She was a delegate to the American Nurses Association conventions in 1980 and 1982 and served on the Illinois Nurses Association Board of Directors.

"The quality of candidates we had seeking the Chief Executive Officer position was outstanding," added NJSNA's Institute for Nursing President, Dr. Mary Ann T. Donohue.  As Search Committee Chairman, Donohue expressed that "in Patricia Barnett, we believe we have found someone who will be a strong advocate for nurses statewide."

About NJSNA

New Jersey State Nurses Association (NJSNA) represents the interests of the state's 110,000 Registered Nurses, advances the profession of nursing and advocates on behalf of nurses and consumers. NJSNA, along with its national organization in Washington, DC, the American Nurses Association (ANA), and fifty- three state and territorial associations, all help to represent the nation's 2.6 million RNs. To learn more about NJSNA visit our website at www.NJSNA.org

Contact: Donald Sico 609-351-3591

SOURCE New Jersey State Nurses Association

RELATED LINKS
http://www.njsna.org

'/>"/>

SOURCE New Jersey State Nurses Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Bristol-Myers Squibb Announces Dividend
2. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
3. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
4. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
7. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
8. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
9. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. Bristol-Myers Squibb to Present at Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... ... ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or were ... careers of all others involved. , On Monday, March 21st, 2017 Laurie Robert, ... Fame. The induction took place during the World of Modular – Award Gala in ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
Breaking Medicine Technology: